HIV & AIDS

New HIV findings reveal genetic double-edged sword

A major international research study involving Murdoch University has found that individuals born with high numbers of a receptor known as HLA-C on their cells can naturally inhibit HIV.

Oncology & Cancer

PR+ cells add prognostic value in luminal A breast cancer

(HealthDay)—Semiquantitative immunohistochemical expression of progesterone receptor-positive tumor cells improves prediction of survival within luminal A breast cancers, according to a study published online Dec. 10 in ...

Oncology & Cancer

Genome packaging: Key to breast cancer development

Cancer is a complex disease and only thanks to advances in genomic techniques have researchers begun to understand, at a cellular and molecular level, the mechanisms which are disrupted in cancer cells. This knowledge is ...

Oncology & Cancer

Metastatic melanoma responds to first-line interleukin-21

(HealthDay)—In the first-line treatment of metastatic melanoma, interleukin-21 (IL-21) shows an overall response rate (ORR) of 22.5 percent and warrants further study, according to research published online Aug. 20 in the ...

Medical research

Estrogen is responsible for slow wound healing in women

Estrogen causes wounds in women to heal slower than in men - who have lower levels of estrogen - says a new study published in the April 2012 issue of the FASEB Journal. In the report, scientists from the University of California, ...

Psychology & Psychiatry

Cannabinoid 2 receptors regulate impulsive behavior

A new study lead by the Neuroscience Institute of Alicante reveals how manipulating the endocannabinoid system can modulate high levels of impulsivity. This is the main problem in psychiatric illnesses such a schizophrenia, ...

Oncology & Cancer

A culprit behind brain tumor resistance to therapy

Persistent protein expression may explain why tumors return after therapy in glioblastoma patients, according to a study published on March 5th in the Journal of Experimental Medicine.

page 6 from 7